Stocktoria

PANACEA LIFE SCIENCES HOLDINGS, INC. PLSH

OTC · stock · Medicinal Chemicals & Botanical Products · website · IPO 2015-11-24

PANACEA LIFE SCIENCES HOLDINGS, INC. (PLSH) earns a Piotroski F-score of 4/9 (mixed financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2023 revenue was $2.4M at a -336.1% net margin.

$0.09 high · $0.03 low · daily closes (~2y) · hover for date & price
23/100
Stocktoria Quality Score · grade D
4/9
Piotroski F — financial health
-13.95
Altman Z″ — distress risk · distress
Dividend yield · no dividend
-4.22
Beneish M-score — earnings quality · low

Quality score trend · recomputed for each fiscal year

Piotroski F /9
1 3 2 1 5 5 4 3 4 201520162017201820192020202120222023
Altman Z″
-4.74 -15.55 -3.50 -3.80 -9.31 -13.95 201520162017201820192020202120222023

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

$0.09 as of 2026-08-01 · +81% 1y
$0.03$0.0952-wk

Beneish M-score: -4.22 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.

Market cap USD$1M
Net margin 5y avg-784.4%
Return on equity 5y avg-76.4%
Beta2.68
Employees40
Revenue trend · last 10y · up

How it ranks in Manufacturing · percentile among 1995 companies

Piotroski Fstronger than 45%
Net marginstronger than 15%

Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 4/9 tests passed

Altman Z″ components · distress zone

ComponentValue
Working capital / assets-0.823
Retained earnings / assets-1.886
EBIT / assets-0.308
Equity / liabilities-0.316

Sector peers · similar-size Manufacturing companies compare side by side →

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
PLSHPANACEA LIFE SCIENCES HOLDINGS, INC.4/9-13.95
RAJAFCordyceps Sunshine Biotech Holdings Co., Ltd.4/9-6.82
NPHCNUTRA PHARMA CORP3/9
NTRRNEUTRA CORP.4/9
FTLFFITLIFE BRANDS, INC.3/91.9951.6-75.3%
BONBon Natural Life Ltd4/94.25-21.7%
CHUCCharlie's Holdings, Inc.3/9-1.3513.2

All Manufacturing companies →

About PANACEA LIFE SCIENCES HOLDINGS, INC.

Panacea Life Sciences Holdings, Inc., operates as a holding company, researchers, develops, manufactures, produces, and distributes cannabinoids, mushrooms, kratom, and other natural, plant-based ingredients and products for humans and animals. It provides a range of products, including Nitro Kava, Kratom, hemp, VAPE products, and various beverages that focuses on promoting alternative health and wellness. The company also offers natural remedies under the PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure, and PANA Life brand names. It manages retail locations and a distribution center in the Tampa, Florida. The company was incorporated in 2008 and is based in Greenwood Village, Colorado.

FAQ

Is PLSH financially healthy?

PANACEA LIFE SCIENCES HOLDINGS, INC.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.

Does PLSH pay a dividend?

No, PANACEA LIFE SCIENCES HOLDINGS, INC. does not currently pay a dividend.

How profitable is PLSH?

In FY2023, PANACEA LIFE SCIENCES HOLDINGS, INC. had a net margin of -336.1%.

Is PLSH a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on PANACEA LIFE SCIENCES HOLDINGS, INC.: a Piotroski F-score of 4/9, an Altman Z″ in the distress zone. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2023-12-31. Facts plus Stocktoria's own computed scores — not investment advice.